VVP
PACB icon

Venture Visionary Partners’s Pacific Biosciences PACB Stock Holding History

Venture Visionary Partners’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$71.8K Hold
30,300
– – ﹤0.01% 699
2026
Q2 		$50.9K Hold
30,300
– – ﹤0.01% 701
2026
Q1 		$40K Hold
30,300
– – ﹤0.01% 633
2025
Q4 		$56.7K Hold
30,300
– – ﹤0.01% 629
2025
Q3 		$38.8K Hold
30,300
– – ﹤0.01% 617
2025
Q2 		$37.6K Buy
30,300
+300
+1% +$346 ﹤0.01% 595
2025
Q1 		$35.4K Hold
30,000
– – ﹤0.01% 565
2024
Q4 		$54.9K Buy
+30,000
New +$58.6K ﹤0.01% 538

Other funds holding PACB

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
DWM
DKM Wealth Management Stockton, California $158M AUM 11.62% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Venture Visionary Partners's PACB Position: Q3 2026 in Review

Venture Visionary Partners held its Pacific Biosciences (PACB) position steady in Q3 2026 at 30,300 shares worth $71.8K. The position accounts for ﹤0.01% of the portfolio, ranked #699.

Venture Visionary Partners first reported a position in PACB in Q4 2024 and has held it in 8 quarters since. 6 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • Venture Visionary Partners held 30,300 shares of Pacific Biosciences worth $71.8K as of Q3 2026.
  • Venture Visionary Partners left its Pacific Biosciences share count unchanged in Q3 2026.
  • Pacific Biosciences made up ﹤0.01% of Venture Visionary Partners's portfolio in Q3 2026, its #699 holding.
  • Venture Visionary Partners first reported a position in Pacific Biosciences in Q4 2024 and has held it in 8 quarters since.
  • 6 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Venture Visionary Partners's 13F filing for Q3 2026, filed 7 Oct 2026.